BRIEF-China Drug Regulator Approves Luye Pharma's Ruoxinlin Anti-Depressant Tablets For Marketing

Reuters | Updated: 03-11-2022 06:49 IST | Created: 03-11-2022 06:49 IST

BRIEF-China Drug Regulator Approves Luye Pharma's Ruoxinlin Anti-Depressant Tablets For Marketing

Luye Pharma Group Ltd:

* CHINA DRUG REGULATOR APPROVES LUYE PHARMA'S RUOXINLIN ANTI-DEPRESSANT TABLETS FOR MARKETING Further company coverage:

TRENDING

1

ROI-The energy transition is starting to feed itself: Maguire

ROI-The energy transition is starting to feed itself: Maguire

Global

2

Georgia block party shooting kills two, injures dozens

Georgia block party shooting kills two, injures dozens

Global

3

Brazil's Flavio Bolsonaro beats polls in presidential vote, faces Lula in runoff

Brazil's Flavio Bolsonaro beats polls in presidential vote, faces Lula in ru...

Global

4

Paraguay opposition candidate wins Asuncion mayor's race in gauge of 2028 vote

Paraguay opposition candidate wins Asuncion mayor's race in gauge of 2028 vo...

Global

PERSPECTIVES AND INSIGHTS

From Imports to Industry: How Vietnam Built a Solar Export Powerhouse on Chinese Supply Chains

Can Social Protection Create Better Jobs? World Bank’s 500 Million Target Faces a Major Test

An Underwater Comeback: Oyster Reef Restoration Is Reshaping Life in Bohai Bay

Switching From Cars to Buses: Public Transport Could Cut Pollution per Traveller

DevShots

Latest News

Connect us on

Facebook Twitter LinkedIn Quora Youtube

Google News RSS

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

Name

Email

Message

By submitting, you agree that we may use your email address to respond.

Web Analytics Made Easy - Statcounter